Michael Holsapple, Executive Director of International Life Sciences Institute,
Health & Environmental Sciences Institute
Society of Toxicology President Elect
The ability to manipulate materials at the nanoscale level, no longer just a laboratory curiosity, is leading to technological advances and practical applications in many areas.
There are now hundreds of nanotechnology products on the market, but uncertainties about the environmental, health and safety impacts may influence public
acceptance and limit the scope of these promising technologies.
Those who are concerned about the environmental, health and safety risks, and those who are eager to invest but need regulatory certainty, both agree that Congress must focus on a policy scheme for nanotechnology.
The ACS Science & the Congress Project in conjunction with the Society of Toxicology and the Society for Risk Analysis
| Linda-Jo Schierow, Environmental Policy Specialist, Congressional Research Service (moderating) E-mail | Biography |
Video of remarks |
| Kristen Kulinowski, Director for External Affairs, Center for Biological and Environmental Nanotechnology, Rice University E-mail | Biography |
Video of Remarks |
| J. Clarence (Terry) Davies, Senior Advisor, Woodrow Wilson Center Project on Emerging Nanotechnologies E-mail | Biography |
Video of remarks |
| James Cooper, Vice President of Petrochemicals, National Petrochemical and Refiners Association E-mail | Biography |
Video of Remarks |
| Charles Auer, Director, Office of Pollution Prevention and Toxics, Environmental Protection Agency Biography |
Video of Remarks |
Log In